ERCC1 and non-small cell lung carcinoma: These pre-clinical results were confirmed in a study with NSCLC patients where ERCC-1 negative tumors presented a higher rate of genomic aberrations as a result of their genetic instability, while a lower number of DNA alterations were seen in ERCC-1 positive NSCLC tumors (20).